On March 23, 2025, Aditxt Inc. amended its merger agreement with Evofem Biosciences, agreeing to invest an additional $1.5 million and extending the merger completion date to September 30, 2025.
AI Assistant
ADITXT INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.